Tuesday / February 7. 2023
menu-logo menu-logo
brand-logo
Subscribe
Subscribe
Tuesday / February 7. 2023
  • Read
    • Daily News
      • Financial
      • Insights
      • U.S.
      • International
    • Digital Issue
    • Cover Stories
    • Feature Articles
    • Company Spotlights
    • Exclusive Interviews
    • Executive Announcements
    • Forward Thinking
    • For You | For Your Field
    • Working Smart
    • New Perspectives
    • From the Publisher
  • Listen & Watch
    • Direct Approach
    • Iconic Insights
    • The DSN Podcast
  • Attend
    • Direct Selling University
    • Global Celebration
  • Achieve
    • Global 100 List
    • CCR Program
    • Best Places to Work
    • Bravo Awards
    • Legends
  • Research
    • Digital Momentum Index
    • Stock Watch
    • Stock Ticker
    • Supplier Directory
    • Resources
  • Engage
    • Supporter Program
    • VIP Text Alerts
  • About
    • About DSN
    • Subscribe
    • Advertise
    • Store
    • Connect
  • Search
Subscribe

Medical Marijuana, Inc. Reports Net Revenue of $9.6 Million in Q2

BY DSN Staff Writer | August 18, 2021 | read / Daily News / Financial

Medical Marijuana, Inc., the parent company of direct selling companies Kannaway and HempMeds, released the financial results from the second quarter of 2021. The company’s net income and net revenue increased 8% and 86% respectively year-over-year. Net revenue totaled $9.6 million for the quarter while net income reached $7 million. Gross profit for the quarter was $5.6 million.

Cash and cash equivalents equaled $6.6 million at the end of the quarter and net cash provided by operating activities was $2 million—one of the highest net cash totals in company history.

Other significant moments in the reporting period include the decriminalization of cannabis in Mexico and the promotion of Blake Schroeder to CEO.

“This being my first quarter as CEO of the company, I am happy to see that we continued to grow in terms of revenue, cash position, and bottom line,” said Medical Marijuana, Inc. CEO Blake Schroeder. “We are working to build a global cannabis company that is not only profitable but one that introduces the power of cannabis to new markets worldwide. In this quarter, we’ve seen great momentum in both our Latin American and Asian businesses. These markets continue to represent tremendous untapped value for our Company where we continue to have a first-mover advantage. Our US and European operations have also remained strong and we are looking forward to continuing to progress as we have in recent months, throughout the remainder of the year. While we continue to plan for the future of Medical Marijuana, Inc., we have our eyes on further global expansion, product innovation, and remaining the leaders in cannabis-based wellness products.”

Posted in Daily News, Financial and tagged Blake Schroeder, HempMeds, Kannaway, Medical Marijuana.
Related Articles
LifeVantage Posts Revenue of $53.7 Million in Q2 of Fiscal 2023  February 06, 2023

LifeVantage Posts Revenue of $53.7 Million in Q2 of Fiscal 2023 

Read more
LR Group Sales Reach $68.4 Million in Q3 2022  December 05, 2022

LR Group Sales Reach $68.4 Million in Q3 2022 

Read more
Telecom Plus Sees 51.5% Revenue Jump   November 22, 2022

Telecom Plus Sees 51.5% Revenue Jump  

Read more
brand-logo
The News You Need.
The Name You Trust.
Subscribe

Breaking global news, emerging trends and powerful stories conveniently curated to help direct selling executives stay informed, engaged and a step ahead.

  • Read
  • Listen & Watch
  • Attend
  • Achieve
  • Research
  • About
  • Connect
5717 Legacy Drive
Suite 250
Plano, Texas 75024
info@directsellingnews.com
Copyright 2023 Direct Selling News | All Rights Reserved
  • Privacy Policy
  • Terms of Use
  • Advertise
  • Subscribe
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT